chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a doctor of pharmacy concerning a 65 year old female with no known drug allergies who on approximately 12 OCT 2001 was vaccinated with pneumococcal vaccine 23 polyvalent. The patient subsequently developed a maculopapular rash over 20% of her body. No other symptoms were reported. The patient sought medical attention for her experience.
Chills; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of CHILLS (Chills) and FATIGUE (Fatigue) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 09L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 28-Jan-2021, the patient experienced CHILLS (Chills) and FATIGUE (Fatigue). At the time of the report, CHILLS (Chills) and FATIGUE (Fatigue) had not resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.  No treatment information was provided.  The patient received both scheduled doses of mRNA-1273 prior to the events therefore, action taken with the drug in response to the events was not applicable.  The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.   This case was linked to US-MODERNATX, INC.-MOD-2021-022474, US-MODERNATX, INC.-MOD-2021-017817, US-MODERNATX, INC.-MOD-2021-010482, US-MODERNATX, INC.-MOD-2021-017800, US-MODERNATX, INC.-MOD-2021-017750, US-MODERNATX, INC.-MOD-2021-010477, US-MODERNATX, INC.-MOD-2021-017674, US-MODERNATX, INC.-MOD-2021-019767, US-MODERNATX, INC.-MOD-2021-019740, US-MODERNATX, INC.-MOD-2021-019718, US-MODERNATX, INC.-MOD-2021-017795, US-MODERNATX, INC.-MOD-2021-028790 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-022474:Crosslinked (MOD21-018132) US-MODERNATX, INC.-MOD-2021-017817:Crosslinked (MOD21-018034) US-MODERNATX, INC.-MOD-2021-010482:Crosslinked (MOD21-018048) US-MODERNATX, INC.-MOD-2021-017800:Crosslinked (MOD21-018071) US-MODERNATX, INC.-MOD-2021-017750:Crosslinked (MOD21-018080) US-MODERNATX, INC.-MOD-2021-010477:Crosslinked (MOD21-018089) US-MODERNATX, INC.-MOD-2021-017674:Crosslinked (MOD21-018092) US-MODERNATX, INC.-MOD-2021-019767:Crosslinked (MOD21-018097) US-MODERNATX, INC.-MOD-2021-019740:Crosslinked (MOD21-018102) US-MODERNATX, INC.-MOD-2021-019718:Crosslinked (MOD21-018111) US-MODERNATX, INC.-MOD-2021-017795:Crosslinked (MOD21-018119) US-MODERNATX, INC.-MOD-2021-028790:Crosslinked (MOD21-018124)
Sick with Respiratory symptoms, laryngitis, weakness, excruciating  flank pain, UTI-like symptoms, high fever. Collapsed and husband called 911, Stroke-like symptoms=partial paralysis especially right side and legs, decreased breathing rate. Hospitalized for almost 2 weeks. Unable to get out of bed, extremely weak. Physical Therapy eventually assisted and noted Proprioception issues. Unable to detect pain, hot or cold sensation although pressure sensation intact. Ears plugged up and unable to hear well intermittently.
Patient complained of soreness/redness, swelling at injection site with general malaise - redness the size of "silver dollar" - continuing several days after injection.
HPI: Got swelling in both shoulders, started day of the vaccines, now 2 days after the vaccines. Right worse than left. Red and warm. No vomiting. No diarrhea. No trouble breathing or swallowing.   Exam: Significant warmth, erythema, and swelling over entire right deltoid. No crepitus, no fluctuance. Left deltoid also with warmth and erythema; swelling limited to 2 cm. No crepitus, no fluctuance.   Assessment: Strong localized reaction but no systemic signs. He received Tdap and MCV, the stronger irritation was from the MCV. Given no prior primer, I suspect that this was more an irritant reaction than an IgE mediated. Treating with anti-histamine.
20-30 minutes after Pfizer vaccine patient became light headed, felt dizzy with blurred vision and some heart palpitations
This spontaneous report as received from a pharmacist via a company representative refers to a 70 year old male patient.  Pertinent medical history included unknown type of cancer. Concomitant therapies and drug allergies were not reported. On an unknown date the patient was vaccinated with ZOSTAVAX (dose, route and lot # not reported) reconstituted with sterile water diluent (manufacturer unknown, dose, lot # and expiration date not reported), to prevent shingles. On an unknown date, approximately 4 weeks from administration, the patient experienced a shingles like rash. The patient did not seek medical attention. The outcome of rash was reported as not recovered/not resolved.
Patient developed hives after second Hep A vaccination.  The patient was treated in our office with Rx for Benadryl.
Approximately 10 minutes after injection, patient complained of itchiness at injection site and itch face. She was given 25mg Benadryl by mouth. 5 minutes later patient complained of hives and was sent to ER for evaluation. Patient is 23 weeks pregnant. 11/18 and 11/20/2009 ED record for 11/4/2009 and OB-GYN records. Pregnant patient with c/o's redness, itching and hives. Tx: IV benadryl. Dx allergic reaction
Patient reported lump near collarbone about "3/4 size of a golfball" that only hurts when pushed. Developed on 7/2/21 in the evening
had Celiac disease and had severe of domino pain for over two weeks, diarrhea, and "explain" rash on her left leg; complete fog brain; itching; all symptoms of Celiac contamination; had Celiac disease and had severe of domino pain for over two weeks, diarrhea, and "explain" rash on her left leg; complete fog brain; itching; all symptoms of Celiac contamination; had Celiac disease and had severe of domino pain for over two weeks, diarrhea, and "explain" rash on her left leg; complete fog brain; itching; all symptoms of Celiac contamination; had Celiac disease and had severe of domino pain for over two weeks, diarrhea, and "explain" rash on her left leg; complete fog brain; itching; all symptoms of Celiac contamination; had Celiac disease and had severe of domino pain for over two weeks, diarrhea, and "explain" rash on her left leg; complete fog brain; itching; all symptoms of Celiac contamination; had Celiac disease and had severe of domino pain for over two weeks, diarrhea, and "explain" rash on her left leg; complete fog brain; itching; all symptoms of Celiac contamination; had Celiac disease and had severe of domino pain for over two weeks, diarrhea, and "explain" rash on her left leg; complete fog brain; itching; all symptoms of Celiac contamination; This is a spontaneous report from a contactable consumer (patient herself). A 49-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection), via an unspecified route of administration, administered in the left arm on 02Apr2021 (batch/lot number and expiration date were unknown) as the 1st dose, single for COVID-19 immunization. The facility where the most recent COVID-19 vaccine was administered was at the pharmacy or drug store. Relevant medical history included Celiac disease and known allergies to Penicillin; both from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient had no COVID prior vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient was not pregnant at the time of vaccination. Since the vaccination, the patient had not been tested for COVID-19. The patient had Celiac disease and had severe of domino pain for over two weeks, diarrhea, and "explain" rash on her left leg; complete fog brain; itching; all symptoms of Celiac contamination on 02Apr2021. The adverse events did result in a doctor or other healthcare professional office/clinic visit. Unspecified therapeutic measures were taken as a result of all the events. The outcome of the events was unknown.  Information on the batch/lot number has been requested.
fell; got a cut with a rusty nail; This is a spontaneous report received from a non-contactable reporter(s) (Consumer or other non HCP) for a Pfizer sponsored program (159558).  A male patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: FALL (non-serious), outcome "unknown", described as "fell"; SKIN LACERATION (non-serious), outcome "unknown", described as "got a cut with a rusty nail". Therapeutic measures were taken as a result of skin laceration.  Additional information: It was reported that week after vaccination, he fell; and got a cut with a rusty nail and got a tetanus shot from that. Patient could not get the second dose because he got the tetanus. Patient wanted to see what would be the process to get the second dose of covid vaccine.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient incorrectly received Pfizer as third dose after receiving Moderna for first two doses.  No AE.
First my left thumb developed "trigger thumb".   It took about a month to  become somewhat normal.  Then the right thumb got trigger finger and I still have it.  I was offered a steroid injection in the thumbs but refused and am trying to get back to normal with hand exercises. I feel this was because I had the Covid Virus in October 2020 and then got the first vaccine in February 2021 and the second in March of 2021. My boyfriend has the same effect of trigger finger in his hand too.
Body ache; cough; Dizziness; Shortness of breath; Chills; congestion; Extreme exhaustion; Diarrhea; Headache; Pain at injection site; This is a spontaneous report received from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6205) via an unspecified route of administration in left arm on 14Mar2021 at 14:15 (at the age of 54-year-old), as single dose for COVID-19 immunisation. The patient medical history included hypothyroidism, high cholesterol and bad cough. The patient had no known allergies. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN), levothyroxine sodium (SYNTHROID), rosuvastatin (MANUFACTURER UNKNOWN), bupropion hydrochloride (BUPRION) and multivitamin (MANUFACTURER UNKNOWN) all for unknown indication. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16Mar2021, the patient experienced vaccination site pain, headache, extreme exhaustion, body aches, diarrhea, chills, dizziness and shortness of breath. The patient reported allergies kicked in during that time as well with congestion and cough. It was reported that patient generally do not experience those symptoms with allergies. Therapeutic measures were taken as a result of flonase and benzonatate. The events did resulted in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events vaccination site pain, headache, exhaustion, body aches, diarrhea, chills, dizziness, shortness of breath, nasal congestion and cough was recovering at the time of report.    No follow-up attempts are needed. No further information is expected.
Headache, itchy eyes, stiff neck on the right (vaccine was given in right arm), body aches, fatigue. This passed within 24 hours EXCEPT for stiff neck and sore arm. Still feel some slight lingering soreness in the area as of today's date (11/12/2012).  Extreme nasal allergy reaction experienced on 11/1 (around 9 pm) for the next 24 hours.  First ever shingles outbreak started on 11/4; diagnosed on 11/9/12.
No additional adverse events reported; The patient was administered with improperly stored vaccine; This spontaneous report was received from a licensed practical nurse referring to a patient of unknown age and gender. Information about the patient's concurrent conditions, medical history, drug reactions/allergies and concomitant therapies was not reported.   On 13-DEC-2021, the patient was vaccinated with improperly stored measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (recombinant Human albumin (rHA)) (M-M-R II) (lot# T033815, expiration date 05-OCT-2022; strength, dose and route were not reported) for prophylaxis (product storage error).  The administered vaccine experienced a temperature excursion in 49.6 Fahrenheit degrees (F) for 35 hours 9 minutes. The previous temperature excursions included 32.9 F for 53 hours 16 minutes, 49.1 F for 5 hours 9 minutes, and 56.3 F for 14 hours 7 minutes. No additional adverse events reported.   This is one of multiple cases received from the same reporter.; Sender's Comments:  US-009507513-2202USA003592: US-009507513-2203USA003312: US-009507513-2203USA003313: US-009507513-2203USA003314: US-009507513-2203USA003315: US-009507513-2203USA003316: US-009507513-2203USA003317: US-009507513-2203USA003318: US-009507513-2203USA003319: US-009507513-2203USA003320: US-009507513-2203USA003335: US-009507513-2203USA003322: US-009507513-2203USA003323: US-009507513-2203USA003324: US-009507513-2203USA003325: US-009507513-2203USA003326: US-009507513-2203USA003327: US-009507513-2203USA003328: US-009507513-2203USA003329: US-009507513-2203USA003330: US-009507513-2203USA003331: US-009507513-2203USA003332: US-009507513-2203USA003333: US-009507513-2203USA003334: US-009507513-2203USA003310: US-009507513-2203USA003321:
1206 Dizziness .second vaccine BP 145/80, HR 89, Resp, 17, Sats 98%. Glucose 165 Hx DM 1224 Dizziness resolved left for home.
Covid like symptoms after receiving the 1st vaccine; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (Covid like symptoms after receiving the 1st vaccine) in a 51-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L20A(orD)) for COVID-19 vaccination.     The patient's past medical history included COVID-19. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) for an unknown indication.    On 31-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Dec-2020, the patient experienced SUSPECTED COVID-19 (Covid like symptoms after receiving the 1st vaccine). At the time of the report, SUSPECTED COVID-19 (Covid like symptoms after receiving the 1st vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No Treatment information provided
No additional adverse effects reported.; A medical assistant states that on 05/29/2020 an improperly stored dose of PROQUAD was administered to a patient.; Information has been received from a Medical Assistant, referring to a patient of unknown age and gender. The patient's medical history, concurrent conditions and concomitant therapies were not reported.  On 29-MAY-2020, the unspecified patient was vaccinated with improperly stored dose of measles, mumps, rubella and varicella (oka-merck) virus vaccine live(PROQUAD) lot # S030093 with expiration date on 24-MAR-2021 as prophylaxis.  No additional adverse effects reported. It was confirm that a digital data logger was involved, also the temperature was reported as 32.7 degrees Fahrenheit (F) during a time frame of 4 hours without a temperature excursion.   This is one of two reports received from the same source.
On my forehead, something strange appeared in a circle shape. Determined as granuolma annulare by my doc.  Also weeks after 2nd stop got a staph infection not sure if related.
headache on and off since then; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (headache on and off since then) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In July 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In July 2021, the patient experienced HEADACHE (headache on and off since then). At the time of the report, HEADACHE (headache on and off since then) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications provided. No treatment information was provided.
PT received a flu injection on 10/17/2005 he called the next day and said he had a temp of 101.8 all that night. it broke around 4am and was doing better.
RASH; This spontaneous report received from a patient concerned a 40 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown, expiry date: UNKNOWN) dose was not reported, administered on 07-APR-2021 for prophylactic vaccination. The batch number was not reported. The company is unable to perform follow-up to request batch/lot no. No concomitant medications were reported.  On 07-APR-2021, the subject experienced rash. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient was recovering from rash. This report was non-serious.
Pt was seen in clinic for vaccine 11/3/23, mom called 11/6/23 to report that over the weekend pt reports that her heart was racing. This has since resolved. Mom wasn't able to state how fast pt HR was at the time.
First vaccine given on 10/28/2021: Pfizer, batch/lot# FH8020.
Peds dose given instead of adult dose. Client called and informed client to return for adult Hep A #1 then follow 6 months for Hep A #2. Medication error.
The pt received influenza (injection) and PPSVS23 in her left arm on 10/15/13. The pt reports that when she received the pneumococcal vaccination the vaccinator.
about 3 days after the vaccination I had rapid heart beats for about 6-8 heart beats in the middle of the night, early morning for 5 days, then it stopped.
Child received a dose of IPOL lot # T1446-2 on 10/22/01, local reaction began 10/23/01, mother of child stated that in the morning of the 23rd it was the size of a knot, later that evening was 9cmx10cm. Was red, swollen and warm, no other symptoms.
soreness in his arm; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (soreness in his arm) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027c21a) for COVID-19 vaccination.     No Medical History information was reported.    On 05-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-May-2021, the patient experienced MYALGIA (soreness in his arm). At the time of the report, MYALGIA (soreness in his arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No  Concomitant medications were provided. No treatment was reported.
This is a spontaneous report from a contactable consumer calling on behalf of her son. This consumer reported different events with the same suspect vaccine (different dose) for the same patient. This is the second of two reports. This 17 year-old male patient received the first single dose of TRUMENBA via an unspecified route of administration on 14Mar2016. The patient medical history and concomitant medications were not reported. After a few days on an unspecified date in Mar 2016 the patient experienced a localized reaction on his arm, that was red and hot to touch around the injection site and that hurt just like the injection site. The pediatrician said it was normal and to not worry. Outcome was unknown. Follow-up (07OCT2016): Follow-up attempt are completed. No further information is expected.
It started with a sore throat. The next day, I was achy and had a definite sore throat. That's when I tested for COVID-19. I had fatigue that day, too. The next day, I started with digestive stuff. I threw up many times and had a little bit of a fever, 99.9. At some point, I got cough, congestion, and runny nose with the sore throat. The aches went away after a few days. The things that remain are cough, congestion, runny nose, and fatigue. I got a prescription of PAXLOVID. I started that the second day. I'm still testing positive for COVID-19 as of yesterday.
After a minute of taking the vaccine shot suddenly he fell on the floor and hit his head, and having a seizure, his eyes turn white, he was immediately lifted and sat down on a chair, he was given water and some snickers chocolate, he was sitting down for probably 10 minutes and then was taken home, he was feeling weak and tired, with the heart raising or strong beats; at home after 20 minutes he vomited and want it to go to sleep, he spend the rest of the day sitting down with some of this symptoms coming and going; his head had a big bump on the back area.
Patient had a staring episode for a few seconds (10-15) and then was post-ictal for about 10 minutes after.  No treatment given.  Mom is a nurse and had him lie down in her arms.  BP after event was 88/52 with a pulse of 108.
Within 2 hours patient noticed overall jitteriness, difficulty breathing...."shortness of breath with exertion" and mild palpitations. Following day, patient noticed chest tightness. She initially took a BENADRYL and then 1 day later took prednisone 10mg-4 tablets at one time. This did help her. The allergist told her to repeat the dose of prednisone in 3 days if needed. She did not feel her breathing was severe enough to go to the ER on 01/22/18. Spoke with pt 01/28/18-took 2 days to resolve. Did not need the 2nd dose of prednisone.
Chronic Fatigue Syndrome. Cognitive dysfunctions. Headache. Myalgia. Asthenia. Orthostatic intolerance. Excessive sweating. Memory and concentration impairment. Low grade fever.
4JAN97 pt recv vax & then screamed x 1 1/2hr then nap/crying on 5JAN97;cried 4hr then slept, cried 1 1/2hr 6JAN97;cried all day dec PO intake;
1st week chills, nausea,  2nd week and 1st week, headache, elevated blood pressure, rash skin folds,   5th week to 1st week increased muscle and joint pain, swollen lymph nodes left underarm and left side of neck, ear congestion,  Continuing 3 months past tachycardia with position changes,
Patient states that a day after injection a rash appeared on the right arm. She felt feverish and monitored her temperature to be over 100 degrees. After two days the fever and rash disappered, however the arm is still sore at the sight of injection.
headaches; runny nose; cold symptoms; body aches; generalized weakness; mild sore throat; This is a spontaneous report from a contactable physician. A 66-years-old male patient (husband) received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection) via an unspecified route of administration on 12Feb2021 as single dose for covid-19 immunisation. Medical history included seasonal allergy and rhinitis allergic that may have caused or increased his symptoms and concomitant medications were not reported. Family medical history included granddaughter had the same allergic rhinitis and colds too. On an unspecified date, the patient experienced headaches, runny nose, cold symptoms, body aches, generalized weakness and mild sore throat. Patient was scheduled for the 2nd dose on 05Mar2021. The outcome of the events was recovering for weakness and rest all recovered.